Auspex Pharmaceuticals, Inc. Insider Trading for October 2014

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Auspex Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Auspex Pharmaceuticals, Inc. for October 2014.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 31 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.331975,38395,11595.3 K to 95.1 K (-0.21 %)
Oct 31 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.337,633208,5823,707,4993.7 M to 3.7 M (-0.21 %)
Oct 31 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.022797,53995,31295.6 K to 95.3 K (-0.29 %)
Oct 31 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.0210,891294,3073,715,1323.7 M to 3.7 M (-0.29 %)
Oct 29 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS26.992757,42295,59195.9 K to 95.6 K (-0.29 %)
Oct 29 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS26.9910,725289,4763,726,0233.7 M to 3.7 M (-0.29 %)
Oct 29 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.11872,35995,86696 K to 95.9 K (-0.09 %)
Oct 29 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.113,41392,5413,736,7483.7 M to 3.7 M (-0.09 %)
Oct 27 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.092727,36795,95396.2 K to 96 K (-0.28 %)
Oct 27 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS27.0910,628287,8663,740,1613.8 M to 3.7 M (-0.28 %)
Oct 27 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS26.741403,74396,22596.4 K to 96.2 K (-0.15 %)
Oct 27 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS26.745,460145,9743,750,7893.8 M to 3.8 M (-0.15 %)
Oct 14 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseM3.8860,151233,3260
Oct 14 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorSellD23.899,771233,3805,270,6045.3 M to 5.3 M (-0.19 %)
Oct 14 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorBuyM3.8860,151233,3265,280,3755.2 M to 5.3 M (+1.15 %)
Oct 14 2014ASPXAuspex Pharmaceuti ...Zisson AlexDirectorOption ExerciseM3.8860,151233,3260
Oct 14 2014ASPXAuspex Pharmaceuti ...Zisson AlexDirectorSellD23.899,771233,3805,270,6045.3 M to 5.3 M (-0.19 %)
Oct 14 2014ASPXAuspex Pharmaceuti ...Zisson AlexDirectorBuyM3.8860,151233,3265,280,3755.2 M to 5.3 M (+1.15 %)
Oct 08 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerOption ExerciseX3.881,0744,1660
Oct 08 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerOption ExerciseX3.8841,892162,4990
Oct 08 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS23.451784,173104,504104.7 K to 104.5 K (-0.17 %)
Oct 08 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerBuyX3.881,0744,166104,682103.6 K to 104.7 K (+1.04 %)
Oct 08 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerSellS23.456,931162,4973,781,2103.8 M to 3.8 M (-0.18 %)
Oct 08 2014ASPXAuspex Pharmaceuti ...CMEA Ventures VII LP10% OwnerBuyX3.8841,892162,4993,788,1413.7 M to 3.8 M (+1.12 %)
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseM3.882439430
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseM3.8864,918251,8170
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorSellD20.604694819,31319.4 K to 19.3 K (-0.24 %)
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorSellD20.6012,226251,8315,147,1435.2 M to 5.1 M (-0.24 %)
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorBuyM3.8824394319,35919.1 K to 19.4 K (+1.27 %)
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorBuyM3.8864,918251,8175,159,3695.1 M to 5.2 M (+1.27 %)
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC3.8889,299346,39189,299
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.86401,850346,3950
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC3.88167,883651,218167,883
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.86755,478651,2220
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC3.8858,667227,56958,667
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.86264,003227,5710
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC3.8859,532230,92559,532
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.86267,899230,9290
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC3.8865,161252,76065,161
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.86293,230252,7640
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.001,106,77900
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.0011,792,52900
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.007,474,41900
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorOption ExerciseC0.002,266,18600
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorBuyP12.0082,475989,7005,113,5675 M to 5.1 M (+1.64 %)
Oct 01 2014ASPXAuspex Pharmaceuti ...Thomas, McNerney & Partners II ...DirectorBuyC0.005,031,09205,031,0920 to 5 M